The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision today affirming a district court ruling that Mylan Pharmaceuticals’ generic hypertension drug did not literally infringe Actelion Pharmaceuticals’ U.S. patents for its own hypertension drug, Veletri®. The CAFC also affirmed the district court’s holding that Actelion had not proven and was barred from asserting infringement by an equivalent.
Yesterday, the U.S. Patent and Trademark Office published a trademark alert highlighting actions that the agency has taken recently to remove fraudulent and otherwise invalid marks from the federal trademark register. In 11 administrative orders issued by the USPTO since the beginning of last October, the agency has either invalidated or is targeting for invalidation around 10,500 trademark applications and registrations for reasons including forged attorney signatures and inventing non-existent trademark registration requirements and fees.
During a Senate Judiciary Subcommittee on Intellectual Property hearing on the Oversight of the U.S. Copyright Office on Tuesday, the intersection of copyright law, artificial intelligence, and executive branch interference were the key focuses. Register of Copyrights Shira Perlmutter provided critical updates on the Copyright Office’s modernization efforts. However, the hearing was punctuated by sharp rebukes from Democratic senators regarding former President Donald Trump’s recent attempts to assert executive control over the legislative branch agency.
Wolf Greenfield is seeking an experienced Patent Agent who is fluent in both English and Korean (written and spoken) to join its Prosecution & Counseling department. This role is ideal for a current Patent Agent with a strong technical background who is interested in applying their expertise to intellectual property strategy, patent preparation, and prosecution for clients that span from major consumer products companies and academic institutions to start-up companies. This position can be based in the firm’s Boston, MA, New York, NY, or Washington, DC office, or fully remote.
Arnold & Porter is a leading international law firm with offices across the United States, Europe, and Asia. The firm delivers sophisticated regulatory, litigation, and transactional services to clients across a wide range of industries. Arnold & Porter is seeking a Senior Manager of IP Prosecution to join its Washington, DC office. This role provides firmwide leadership for the Intellectual Property Prosecution function, overseeing patent and trademark operations and ensuring the delivery of efficient, high-quality support to attorneys and clients.
I keep hearing the same thing from patent professionals across the industry—inside companies, inside law firms, and even from investors. Patent budgets are shrinking, expectations are rising, and nobody seems willing to admit what that combination actually means.
This week on IPWatchdog Unleashed, I had the pleasure of speaking with Deborah Farone, founder of Farone Advisors, former Chief Marketing Officer of Cravath, Swain & Moore, and author of Breaking Ground: How Successful Women Lawyers Build Thriving Practices. Our conversation focused on how lawyers—particularly in highly technical fields like intellectual property—can build thriving practices through disciplined, strategic business development. The discussion underscores that business development is a skill, not an innate personality trait. Even introverted attorneys can succeed by taking incremental steps, practicing authentic communication, and focusing on listening rather than selling.
The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a decision today affirming the dismissal of a pro se lawsuit brought by three inventors who contested the U.S. Patent and Trademark Office’s (USPTO) refusal to grant them reduced filing fees. The CAFC found that the inventors failed to adequately plead Article III standing, as their own representations to the USPTO undermined any claim of ownership in the disputed application.
The U.S. Court of Appeals for the Federal Circuit (CAFC) on Monday affirmed a district court decision awarding attorney fees and costs to Nextremity Solutions, Inc. for an infringement suit brought against it by Extremity Medical, LLC, but denying attorney fees and costs for the successful parallel inter partes review proceeding (IPR) Nextremity pursued. The opinion was authored by Judge Lourie.
Wolf Greenfield is seeking an experienced Patent Agent to join its Prosecution & Counseling department. This role is ideal for a current Patent Agent with a strong technical background who is interested in applying their expertise to intellectual property strategy, patent preparation, and prosecution for clients that span from major consumer products companies and academic institutions to start-up companies. This position can be based in the firm’s Boston, MA, New York, NY, or Washington, DC office, or fully remote.
This week on IPWatchdog Unleashed we discuss whether patent owners are better off facing post-grant challenges at the Patent Trial and Appeal Board (PTAB) or the Central Reexamination Unit (CRU) at the United States Patent and Trademark Office (USPTO). PTAB practitioners Matt Phillips and Kevin Greenleaf joined me for about how patent owners and challengers should be strategically thinking about the shifting post-grant environment at the USPTO. Our conversation highlights the growing reality that post-grant practice is no longer defined solely by inter partes review (IPR), but that ex parte reexamination has seen a resurgence in popularity, which requires careful evaluating timing, procedural dynamics, cost, and institutional realities. Fundamentally we attempt to answer the question of whether patent owners are better off in reexamination, or whether they are better off with IPR at the PTAB.
The U.S. Supreme Court on Monday denied certiorari in Zioness Movement, Inc. v. The Lawfare Project, Inc., a case in which Zioness Movement sought review of a U.S. Court of Appeals for the Second Circuit decision that upheld a jury verdict allowing two competing nonprofit entities to co-own the “Zioness” trademark.
Today, the U.S. Supreme Court issued an order list including the denial of a petition for writ of certiorari filed by Dr. Stephen Thaler that challenged federal agency and court rulings preventing copyright registration for an image generated entirely by artificial intelligence (AI). In following the U.S. Solicitor General’s call to deny cert to Thaler’s appeal, the Supreme Court declined invitations from both sides of the AI authorship debate to clarify the copyrightability of works that are substantially AI-generated.
This is the best way to stay informed. We send a daily roundup of our latest news, press releases, and events.
Get Email Updates